Radiodermatitis Market to Rise at a CAGR of 3.3% during Forecast Period, observes TMR Study

The global market for radiodermatitis is projected to be driven by an increase in cancer occurrence worldwide and the prevalence of co-morbid conditions

Wilmington, Delaware, United States, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - According to insights on the radiodermatitis market, in 2018, the global radiodermatitis market was worth US$ 334.2 Mn. The global market is estimated to progress at a CAGR of 3.3% during the forecast period, from 2019 to 2027. The market value of the radiodermatitis is expected to reach valuation of US$ 506.3 Mn by 2027. The sales of radiodermatitis market is anticipated to be driven by an increasing cancer incidence throughout the world, innovative product offerings, industry-academia collaboration, but also growing access to health care.

By 2032, the WHO projects that there will be 22 million newly diagnosed cancer cases and that there will be 9.6 million cancer-related deaths. The International Agency for Research on Cancer (IARC) estimates that 18.1 million new instances of cancer are diagnosed worldwide each year. Additionally, it is anticipated that the incidence of several malignancies, including head and neck and breast cancer, would rise. This can be attributed to unhealthy lifestyle choices like smoking for neck and head cancers and obesity for breast cancer. Furthermore, radiation therapy is administered locally for these tumors. As a result, radiation-induced dermatitis is more likely to occur in individuals with certain malignancies.

The expansion of the radiodermatitis market is further attributed to greater emphasis on research to identify and achieve better-quality treatment options. Players have a great opportunity to put their novel product ideas on the road to commercial success since there aren't many standard care products available on the market.

Get Exclusive PDF Sample Copy of Radiodermatitis Market Report –

Key Findings of Market Report

  • People who are overweight and/or diabetic are at an increased risk of cancer due to the significant rise in these conditions. This component is probably going to increase the occurrences of radiodermatitis and raise the requirement for radiation therapy.

  • In regions that have a large proportion of cancer patients receiving radiation therapy, product sales typically tend to be higher. Asia Pacific tops the globe in both the number of cancer incidences and also the number of patients receiving radiation treatment alone or in conjunction with chemotherapy. As such, the region is expected to account for a considerable market share for radiodermatitis in the years to come.

Ask for References –

Global Radiodermatitis Market: Key Players

Some of the key market players are

  • Integra Life Sciences
  • Molnlycke Health Care AB
  • BMG Pharma
  • 3M Company
  • Smith & Nephew plc.
  • ConvaTec Inc

Global Radiodermatitis Market: Segmentation


  • Topical
  • Oral Medication
  • Dressings

Make an Enquiry Before Buying

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy Store
  • Online Store

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Bioprocess Technology Market: The global bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031 with a CAGR of 8.3% from 2021 to 2031.

Animal Genetics Market: The global animal genetics market is anticipated to reach more than US$ 9.1 Bn by the end of 2031 with a CAGR of 6.7% from 2022 to 2031.

Soft Tissue Allografts Market: The global soft tissue allografts market is anticipated to reach more than US$ 6.3 Bn by the end of 2031 with a CAGR of 5.5% from 2022 to 2031.

PRP and PRF in Cosmetics Market: The global PRP and PRF in cosmetics market is anticipated to exceed US$ 483 Mn by 2031 with a CAGR of 12.6% from 2022 to 2031.

Fetal Bovine Serum Market: The global fetal bovine serum market is expected to surpass the value of US$ 1.6 Bn by the end of 2031 with a CAGR of 6.4% from 2021 to 2031.

Cell Culture Market: The global cell culture market is expected to reach the value of US$ 27.6 Bn by the end of 2031 with a CAGR of 9% from 2021 to 2031.

Sample Preparation Market: The sample preparation market size stood at US$ 5.6 Bn. Sample preparation market demand analysis estimate that the market will progress at a CAGR of 6.6% during the forecast period, from 2019 to 2027.

Molecular Diagnostics Market: The global molecular diagnostics market is expected to reach the value of US$ 37.19 Bn by the end of 2028 with a CAGR of 11.1% from 2021 to 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453